Evoke Pharma Inc

NASDAQ:EVOK

1.90

+0.01 (+0.54%)

5:17:51 PM EDT: $1.81 -0.09 (-4.74%)

Market Cap (Intraday)	6.39M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1 Million
Adjusted EPS	-$0.58

See more estimates

10-Day MA	$2.31
50-Day MA	$3.32
200-Day MA	$2.64

See more pivots

Evoke Pharma Inc Stock, NASDAQ:EVOK

420 Stevens Avenue, Suite 370, Solana Beach, California 92075-2074

United States of America

Phone: +1.858.345.1494

Number of Employees: 4

http://www.evokepharma.com

Description

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.